Creso Pharma : Application for quotation of securities - CPH

Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

CRESO PHARMA LIMITED

Announcement Type

New announcement

Date of this announcement

Thursday July 14, 2022

The +securities to be quoted are:

Other

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
CPH	ORDINARY FULLY PAID	100,000	14/07/2022

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 8

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

CRESO PHARMA LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2	Registered number type	Registration number
ABN	89609406911
1.3	ASX issuer code
CPH

1. The announcement is New announcement
2. Date of this announcement

14/7/2022

Application for quotation of +securities

2 / 8

Application for quotation of +securities

Part 2 - Type of Issue

2.1 The +securities to be quoted are: Other

For personal use only

2.2 The +securities to be quoted are:

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS? No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

The issue has not been previously announced to the market in an Appendix 3B because the date of the agreement to issue the securities is the same date as the actual date of issue of the securities.

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:

The publication of a +disclosure document or +PDS involving the same class of securities as the +securities to be quoted that meets the requirements of section 708A(11) or 1012DA(11)

Application for quotation of +securities

3 / 8

Application for quotation of +securities

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an

Appendix 3B

only	Additional +securities to be quoted in an existing class
ASX +security code and description
	CPH : ORDINARY FULLY PAID
	Issue date
	14/7/2022
use	Will the +securities to be quoted rank equally in all respects from their issue date with the

existing issued +securities in that class? Yes

Issue details

For personal

Number of +securities to be quoted

100,000

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

100,000 shares issued to the nominee of Mr Van Biezen, as part consideration for his services under his Brand Ambassador and Strategic Adviser Agreement with subsidiary, Creso Pharma ImpACTIVE Inc.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

3,900.000000

Any other information the entity wishes to provide about the +securities to be quoted

The estimated consideration is arbitrary and was calculated solely for the purpose of this Appendix 2A, based on the closing price of CPH Shares at 13 July 2022.

The purpose(s) for which the entity is issuing the securities

To pay for services rendered

Please provide additional details

Further details are set out in the ASX release dated 14 July 2022.

Application for quotation of +securities

4 / 8

Application for quotation of +securities

For personal use only

Application for quotation of +securities

5 / 8